SPEAKERS

Tom Beer

Tomasz M. Beer

Professor of Medicine, Division of Hematology/Medical Oncology
Oregon Health & Science University

#EDx21

Hans Clevers

Group leader
Hubrecht Institute

#EDx21

Stacey Fedewa

Senior Principal Scientist, Surveillance Research
American Cancer Society

Susan Galbraith

Susan Galbraith

Senior Vice President and Head of Research and Early Development, Oncology R&D
Astrazeneca

#EDx21

Livia Giordano

CPO
Piemonte

#EDx21

Daniel A. Helle

Lab Head
Memorial Sloan Kettering Cancer Centre

Usha Menon

Usha Menon

Professor of Gynaecological Cancer
University College London

Henry Scowcroft

Henry Scowcroft

Author of Cross Everything
Communications Strategy
Cancer Research UK

#EDx21

Avi Spira

Global Head of the Lung Cancer Initiative
Johnson & Johnson

Charles Swanton

Charles Swanton

Senior Group Leader of the Cancer Evolution and Genome Instability Laboratory
The Francis Crick Institute

Thea Tlsty

Thea D. Tlsty

Professor, Department of Pathology and Director of the Center for Translational Research in the Molecular Genetics of Cancer
University of California

#EDx21

Robert Winn

Director
VCU Massey Cancer Center

SESSION CHAIRS

Joan Brugge

Joan S. Brugge

Director of the Harvard Ludwig Cancer Center and Professor of Cell Biology
Harvard Medical School

Billy Boyle

Billy Boyle

Co-founder and CEO
Owlstone Medical

Christina Curtis

Christina Curtis

Associate Professor and Endowed Faculty Scholar in the Departments of Medicine and Genetics
Stanford University

Robert Smith

Robert Smith

Vice President of Cancer Screening at the National Office
American Cancer Society